InflaRx plans to launch Covid antibody with five-figure price tag

Nicole DeFeudis

Editor

A day after winning emergency use authorization for its Covid-19 antibody, InflaRx said it has enough supply ready to treat several thousand patients. However, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

InflaRx plans to launch Covid antibody with five-figure price tag

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

In­flaRx plans to launch Covid an­ti­body with five-fig­ure price tag

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

InflaRx plans to launch Covid antibody with five-figure price tag